Use of Mouthwash in Preventing Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)

Use of Mouthwash in Preventing Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)

Loading document ...
Page
of
Loading page ...

Author(s)

Author(s): Eunice Taeyeon Kim

Download Full PDF Read Complete Article

DOI: 10.18483/ijSci.2568 14 45 1-3 Volume 11 - Mar 2022

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a virus that enters the respiratory tract through the nose and mouth affects a wide range of cells and systems of the body, causing various types of symptoms. Therefore, the discovery that the use of mouthwash may help prevent COVID-19 from entering the body is a breakthrough and an area of interest for research. In this report, several research papers about the effects of mouthwash in preventing COVID-19 are evaluated and different types of mouthwash are discussed. In particular, one randomized prospective cohort study presented the promising result of chlorhexidine mouthwash and spray in preventing COVID-19. Despite the result, the number of clinical trials is lacking, and more clinical trials need to be performed to obtain more conclusive clinical evidence that the mouthwash indeed has a preventive effect on SARS-CoV-2 transmission.

Keywords

Coronavirus

References

  1. A. Vergara-Buenaventura and C. Castro-Ruiz. “Use of mouthwashes against COVID-19 in dentistry”. British Journal of Oral & Maxillofacial surgery, Vol. 58, No. 8, pp. 924–927, October 2020. https://doi.org/10.1016/j.bjoms.2020.08.016
  2. Gururaj Arakeri and Vishal Rao US. “Methylene blue as an anti-COVID-19 mouthwash in dental practice.” British Journal of Oral & Maxillofacial Surgery, Vol. 59, No. 1, pp. 135–136, January 2021. https://doi.org/10.1016/j.bjoms.2020.09.018
  3. Y. Hanna Huang and Jong T. Huang. “Use of chlorhexidine to eradicate oropharyngeal SARS-CoV-2 in COVID-19 patients”. Journal of Medical Virology, Vol. 93, No. 7, pp. 4370–4373, July 2021. https://doi.org/10.1002/jmv.26954
  4. Henry Daniell, et al. “Debulking SARS-CoV-2 in saliva using angiotensin converting enzyme 2 in chewing gum to decrease oral virus transmission and infection” (published online ahead of print). Molecular Therapy, November 2021. https://doi.org/10.1016/j.ymthe.2021.11.008

Cite this Article:

International Journal of Sciences is Open Access Journal.
This article is licensed under a Creative Commons Attribution 4.0 International (CC BY 4.0) License.
Author(s) retain the copyrights of this article, though, publication rights are with Alkhaer Publications.

Search Articles

Issue October 2022

Volume 11, October 2022


Table of Contents



World-wide Delivery is FREE

Share this Issue with Friends:


Submit your Paper